1st July 2022
- 0 comments
Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS).
The fundraising round by Cytomos was led by existing investor Archangels with participation from Scottish Enterprise and Old College Capital.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.